Kaitlyn D’Onofrio

DocwireNews

<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/1-in-3-patients-with-autoimmune-diseases-uncertain-about-covid-19-vaccine/">1 in 3 Patients With Autoimmune Diseases Uncertain About COVID-19 Vaccine</a>Although about half of patients with autoimmune diseases are willing to get the COVID-19 vaccine, about a third remain uncertain about it, <a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/1-in-3-patients-with-autoimmune-diseases-uncertain-about-covid-19-vaccine/">according to a study</a>, suggesting there is an opportunity for healthcare professionals to provide education to their patients.The international VAXICOV (VAccinations against COVid-19) study surveyed 1,266 patients with systemic autoimmune or inflammatory rheumatic diseases. Just over half of patients said they were willing to get vaccinated, but notably, about a third reported uncertainty. Vaccine willingness increased with age and was also largely associated with the fear of being infected with and getting severe COVID-19.Patients said they most trusted their specialist&mdash;such as their rheumatologist or internist&mdash;in terms of recommending to get the COVID-19 vaccine, followed by their general practitioner. When recommended by a physician, the willingness to get vaccinated increased to 62.8%, and uncertainty and unwillingness to 28.4% and 8.8%, respectively.https://www.docwirenews.com/docwire-pick/rheumatology-picks/1-in-3-patients-with-autoimmune-diseases-uncertain-about-covid-19-vaccine/<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/could-anakinra-be-used-to-treat-severe-covid-19/">Could Anakinra Be Used To Treat Severe COVID-19?</a>The results of a new study suggest that there may be a way to use <a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/could-anakinra-be-used-to-treat-severe-covid-19/">anakinra in the treatment of severe COVID-19</a>. The study, which is currently in preprint, assessed the use of personalized immunotherapy in patients critically ill with COVID-19 and concluded, &ldquo;Biomarkers may guide favorable anakinra responses in critically ill patients with COVID-19.&rdquo;https://www.docwirenews.com/docwire-pick/rheumatology-picks/could-anakinra-be-used-to-treat-severe-covid-19/<a href="https://www.docwirenews.com/condition-center/orthopedicscc/orthopedics-center-picks/artificial-intelligence-decision-aid-a-significant-benefit-for-patients-with-oa-considering-knee-replacement/">AI Decision Aid A Significant Benefit For Patients with OA Considering Knee Replacement</a>A randomized, clinical trial found that patients with osteoarthritis (OA) of the knee who are thinking of undergoing total knee replacement (TKR) may benefit from an artificial intelligence (AI)-enabled decision aid. &ldquo;The findings of this study suggest that multifaceted decision aids integrating patient education, preference assessment, and AI-enabled analytics built with patient-reported outcome measure data can provide a personalized, data-driven approach to shared-decision making for patients with advanced knee OA considering TKR,&rdquo; the researchers wrote in their conclusion.https://www.docwirenews.com/condition-center/orthopedicscc/orthopedics-center-picks/artificial-intelligence-decision-aid-a-significant-benefit-for-patients-with-oa-considering-knee-replacement/

Jordana Jampel

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Eric Bergson, MD

Rob Dillard

The Role of Multidisciplinary Care in Head and Neck Cancer

Head and Neck Cancer

Sara Nunnery, MD, MSCI

Trastuzumab Deruxtecan in HER2-Low Breast Cancer: Who’s the Right Patient?

HER2 Breast Cancer

Latest News

Rheum Round-up: 1 in 3 Autoimmune Pts Uncertain About Vaccine, Anakinra to Treat COVID?, and more

Rheumatology

1 in 3 Patients With Autoimmune Diseases Uncertain About COVID-19 Vaccine ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe